Royal Bank Of Canada Amyris, Inc. Transaction History

Royal Bank Of Canada

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.58 - $1.3 $3,298 - $7,393	5,687 Added 35.68%	21,625 $22,000
Q1 2023 May 15, 2023	SELL	$1.09 - $1.82 $25,897 - $43,241	-23,759 Reduced 59.85%	15,938 $21,000
Q4 2022 Feb 14, 2023	BUY	$1.52 - $3.39 $52,622 - $117,361	34,620 Added 681.9%	39,697 $60,000
Q3 2022 Nov 14, 2022	SELL	$1.7 - $4.05 $39,309 - $93,648	-23,123 Reduced 82.0%	5,077 $15,000
Q2 2022 Aug 15, 2022	SELL	$1.6 - $5.07 $16,328 - $51,739	-10,205 Reduced 26.57%	28,200 $52,000
Q1 2022 May 16, 2022	SELL	$3.92 - $5.86 $90,469 - $135,242	-23,079 Reduced 37.54%	38,405 $167,000
Q4 2021 Feb 14, 2022	BUY	$5.0 - $14.85 $102,860 - $305,494	20,572 Added 50.28%	61,484 $332,000
Q3 2021 Nov 15, 2021	BUY	$12.13 - $16.99 $250,047 - $350,231	20,614 Added 101.56%	40,912 $561,000
Q2 2021 Aug 16, 2021	BUY	$10.82 - $19.37 $219,624 - $393,172	20,298 New	20,298 $332,000

230K

Ticker AMRS
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 324,860,000
Market Cap $3.25M
Description
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.